145 related articles for article (PubMed ID: 35758926)
1. Protective Effect of Cardiomyocyte-Specific Prolyl-4-Hydroxylase 2 Inhibition on Ischemic Injury in a Mouse MI Model.
Pradeep SR; Lim ST; Thirunavukkarasu M; Joshi M; Cernuda B; Palesty JA; Maulik N
J Am Coll Surg; 2022 Aug; 235(2):240-254. PubMed ID: 35758926
[TBL] [Abstract][Full Text] [Related]
2. Targeted gene deletion of prolyl hydroxylase domain protein 3 triggers angiogenesis and preserves cardiac function by stabilizing hypoxia inducible factor 1 alpha following myocardial infarction.
Oriowo B; Thirunavukkarasu M; Selvaraju V; Adluri RS; Zhan L; Takeda K; Fong GH; Sanchez JA; Maulik N
Curr Pharm Des; 2014; 20(9):1305-10. PubMed ID: 23978105
[TBL] [Abstract][Full Text] [Related]
3. [Effect of
Li XY; Wu CH; Yan YJ; Wang DH; Wang MJ; Hou ZW
Zhongguo Zhen Jiu; 2022 Nov; 42(11):1278-84. PubMed ID: 36397226
[TBL] [Abstract][Full Text] [Related]
4. Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.
Adluri RS; Thirunavukkarasu M; Dunna NR; Zhan L; Oriowo B; Takeda K; Sanchez JA; Otani H; Maulik G; Fong GH; Maulik N
Antioxid Redox Signal; 2011 Oct; 15(7):1789-97. PubMed ID: 21083501
[TBL] [Abstract][Full Text] [Related]
5. Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.
Xie L; Pi X; Wang Z; He J; Willis MS; Patterson C
J Mol Cell Cardiol; 2015 Mar; 80():156-65. PubMed ID: 25633836
[TBL] [Abstract][Full Text] [Related]
6. TXNIP knockout improves cardiac function after myocardial infarction by promoting angiogenesis and reducing cardiomyocyte apoptosis.
Wang J; Wang XJ; Zhang Y; Shi WJ; Lei ZD; Jiao XY
Cardiovasc Diagn Ther; 2022 Jun; 12(3):289-304. PubMed ID: 35800356
[TBL] [Abstract][Full Text] [Related]
7. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia.
Kunze R; Zhou W; Veltkamp R; Wielockx B; Breier G; Marti HH
Stroke; 2012 Oct; 43(10):2748-56. PubMed ID: 22933585
[TBL] [Abstract][Full Text] [Related]
8. Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction.
Huang M; Nguyen P; Jia F; Hu S; Gong Y; de Almeida PE; Wang L; Nag D; Kay MA; Giaccia AJ; Robbins RC; Wu JC
Circulation; 2011 Sep; 124(11 Suppl):S46-54. PubMed ID: 21911818
[TBL] [Abstract][Full Text] [Related]
9. Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury.
Zhao Y; Zeng H; Liu B; He X; Chen JX
Am J Physiol Renal Physiol; 2020 Aug; 319(2):F345-F357. PubMed ID: 32715763
[TBL] [Abstract][Full Text] [Related]
10. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice.
Chen JX; Stinnett A
Diabetes; 2008 Dec; 57(12):3335-43. PubMed ID: 18835934
[TBL] [Abstract][Full Text] [Related]
11. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
[TBL] [Abstract][Full Text] [Related]
13. Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia.
Rishi MT; Selvaraju V; Thirunavukkarasu M; Shaikh IA; Takeda K; Fong GH; Palesty JA; Sanchez JA; Maulik N
Microvasc Res; 2015 Jan; 97():181-8. PubMed ID: 25446011
[TBL] [Abstract][Full Text] [Related]
14. The novel prolyl hydroxylase-2 inhibitor caffeic acid upregulates hypoxia inducible factor and protects against hypoxia.
Guo Z; Yang Y; Li L; Zhao Q; Li Y; Liu Z; Hao L; Guo B; Diao A
Eur J Pharmacol; 2022 Nov; 934():175307. PubMed ID: 36191632
[TBL] [Abstract][Full Text] [Related]
15. Glutaredoxin-1 overexpression enhances neovascularization and diminishes ventricular remodeling in chronic myocardial infarction.
Adluri RS; Thirunavukkarasu M; Zhan L; Dunna NR; Akita Y; Selvaraju V; Otani H; Sanchez JA; Ho YS; Maulik N
PLoS One; 2012; 7(3):e34790. PubMed ID: 22523530
[TBL] [Abstract][Full Text] [Related]
16. Topical prolyl hydroxylase domain-2 silencing improves diabetic murine wound closure.
Wetterau M; George F; Weinstein A; Nguyen PD; Tutela JP; Knobel D; Cohen Ba O; Warren SM; Saadeh PB
Wound Repair Regen; 2011; 19(4):481-6. PubMed ID: 21627711
[TBL] [Abstract][Full Text] [Related]
17. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
[TBL] [Abstract][Full Text] [Related]
18. Localized Delivery of shRNA against PHD2 Protects the Heart from Acute Myocardial Infarction through Ultrasound-Targeted Cationic Microbubble Destruction.
Zhang L; Sun Z; Ren P; You M; Zhang J; Fang L; Wang J; Chen Y; Yan F; Zheng H; Xie M
Theranostics; 2017; 7(1):51-66. PubMed ID: 28042316
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
Han WQ; Zhu Q; Hu J; Li PL; Zhang F; Li N
Biochim Biophys Acta; 2013 Jun; 1833(6):1454-62. PubMed ID: 23466866
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury.
Hölscher M; Silter M; Krull S; von Ahlen M; Hesse A; Schwartz P; Wielockx B; Breier G; Katschinski DM; Zieseniss A
J Biol Chem; 2011 Apr; 286(13):11185-94. PubMed ID: 21270129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
